Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.2071
Schlusskurs vom Vortag:
$0.2071
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$17.18M
Einnahmen:
$2.41M
Nettoeinkommen (Verlust:
$-42.50M
KGV:
0.00
EPS:
-1.1
Netto-Cashflow:
$-36.15M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$2.40
Renalytix Plc Adr Stock (RNLX) Company Profile
Firmenname
Renalytix Plc Adr
Sektor
Branche
Telefon
44 29 2071 0570
Adresse
FINSGATE, LONDON
Vergleichen Sie RNLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RNLX
Renalytix Plc Adr
|
0.00 | 17.18M | 2.41M | -42.50M | -36.15M | -0.90 |
|
VEEV
Veeva Systems Inc
|
224.15 | 36.39B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
66.83 | 11.55B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
57.83 | 10.80B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
94.95 | 8.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.82 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Renalytix Plc Adr Stock (RNLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-01-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-01-04 | Eingeleitet | BTIG Research | Buy |
| 2021-10-04 | Eingeleitet | Guggenheim | Buy |
| 2021-07-02 | Eingeleitet | Berenberg | Buy |
| 2020-08-11 | Eingeleitet | Stifel | Buy |
Renalytix Plc Adr Aktie (RNLX) Neueste Nachrichten
Renalytix executives engage in share transactions - Investing.com
Stock Market Recap: Renalytix Plc ADR (RNLX) Concludes at 0.21, a 5.66 Surge/Decline - The Dwinnex
Commencement of trading on OTCQB in the United States - StockTitan
What was Renalytix Plc ADR (RNLX)’s performance in the last session? - US Post News
Renalytix Plc ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle
Ratios in Focus: Analyzing Renalytix Plc ADR (RNLX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Renalytix AI stock hits 52-week low at $0.22 amid market challenges - Investing.com
Renalytix Plc ADR (RNLX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
There is no way Renalytix Plc ADR (RNLX) can keep these numbers up - SETE News
How analysts predict Renalytix Plc ADR (RNLX) will perform this quarter? - US Post News
Renalytix Plc ADR (RNLX) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Investor’s Delight: Renalytix Plc ADR (RNLX) Closes Strong at 0.31, Up 7.31 - The Dwinnex
Renalytix Plc ADR (RNLX) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Analyzing RNLX’s price-to-book ratio for the last quarter - US Post News
Renalytix Plc ADR (RNLX) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Closing Figures: Renalytix Plc ADR (RNLX)’s Negative Finish at 0.31, Down -23.14 - The Dwinnex
Form 8.5 (EPT/RI)-Renalytix Plc - GlobeNewswire Inc.
Investing in Renalytix Plc ADR (RNLX) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Check out these key findings about Renalytix Plc ADR (RNLX) - SETE News
Renalytix Plc ADR Inc. (RNLX) Price Performance Over the Years: A Comparative Study - The InvestChronicle
What to expect from Renalytix Plc ADR’s (RNLX) current quarter earnings? - US Post News
Examining Renalytix Plc ADR (RNLX) more closely is necessary - US Post News
It is Poised to be a Bull Market for Renalytix Plc ADR (RNLX) - SETE News
Upward Trajectory: Renalytix Plc ADR (RNLX) Posts a Gaine, Closing at 0.34 - The Dwinnex
Is Renalytix Plc ADR (RNLX) a good investment opportunity? - US Post News
Renalytix Plc ADR Inc. (RNLX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Renalytix AI shares hold buy rating from HC Wainwright - Investing.com
- Invest Chronicle - The InvestChronicle
Barclays raises Alkami Technology target to $31 on growth outlook By Investing.com - Investing.com India
Renalytix Partners with Steno for Kidney Care in Europe - Investing.com
Did Renalytix Plc ADR (RNLX) perform well in the last session? – US Post News - US Post News
Market Watch Highlights: Renalytix Plc ADR (RNLX) Ends on an Upturn Note at 0.25 – DWinneX - The Dwinnex
Investing in Renalytix Plc ADR (RNLX) might be an excellent idea, but the stock is currently overvalued/undervalued ... - US Post News
Check out these key findings about Renalytix Plc ADR (RNLX) – Sete News - SETE News
Post-Trade Analysis: Renalytix Plc ADR (RNLX) Slides -28.97, Closing at 0.25 – DWinneX - The Dwinnex
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination - Yahoo Finance UK
Renalytix Plc ADR (RNLX) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Renalytix Plc Share Chat (RENX) - London South East
Cummins raises dividend as streak continues By Investing.com - Investing.com
Renalytix faces delisting from Nasdaq over noncompliance - Investing.com India
Renalytix appoints CohnReznick as new auditor By Investing.com - Investing.com
Renalytix plc successful completion of $30.0 million financing package - The Globe and Mail
Renalytix to Report Second Quarter and First Half Fiscal Year 2022 Financial Results on March 31 - The Globe and Mail
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022 - The Globe and Mail
Renalytix Appoints Ann Berman to its Board of Directors - The Globe and Mail
Renalytix Plc Share Chat. Chat About RENX SharesStock Quote, Charts, Trade History, Share Chat, Financial Terms ... - London South East
Medicare sets $950 price for Renalytix kidney test - Investing.com
WaFd Inc. set to release quarterly earnings mid-July By Investing.com - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
US to block Tempur Sealy's $4 billion buy of retailer Mattress Firm By Reuters - Investing.com
Fragrant Prosperity slumps as reverse takeover falls through - Proactive Investors USA
Finanzdaten der Renalytix Plc Adr-Aktie (RNLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.16%
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):